Observational studyAnnals of hematology2024

Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.

Noriharu Nakagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.